About Dementias Platform
Dementias Platform is a company based in Oxford (United Kingdom) founded in 2014 by Feyi Raimi-Abraham. It operates as a B2B and Non-Profit Collaboration. Dementias Platform offers products and services including Data Portal, Trials Delivery Framework, and Experimental Medicine Incubator. Dementias Platform operates in a competitive market with competitors including Inato, goBalto, NoviSci, Acme Clinical Trials and Clinata, among others.
- Headquarter Oxford, United Kingdom
- Founders Feyi Raimi-Abraham
- SectorsHealthcare
- Email••••••••
- Website dementiasplatform.uk
- Social LinkedIn X
Products & Services of Dementias Platform
Dementias Platform offers a comprehensive portfolio of products and services, including Data Portal, Trials Delivery Framework, and Experimental Medicine Incubator.
Secure platform for accessing health research records and datasets
System to match volunteers to dementia studies across the UK
Accelerates development of new dementia treatments and therapies
People of Dementias Platform
1 people are tracked at Dementias Platform (1 in leadership).
| Name | Role | Group |
|---|---|---|
Feyi Raimi-Abraham | Founder, CEO | Leadership |
Complete people profiles for Dementias Platform
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Dementias Platform
Dementias Platform operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inato, goBalto, NoviSci, Acme Clinical Trials and Clinata, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inato.com | 2016 | Paris, France | $35.52M | – | AI-based patient recruitment platform | |
| gobalto.com | 2008 | San Francisco, United States | $38.25M | 66 | Cloud-based SaaS solutions for clinical trial startup are offered. | |
| novisci.com | 2016 | Durham, United States | – | – | Provider of an online scientific sourcing tool for researchers and professionals | |
| aclinicaltrials.com | 2017 | San Jose, United States | – | – | Provides an online database of clinical trial studies for researchers. | |
| clinata.com | 2012 | Dallas, United States | $100,000 | – | Online Clinical Research Marketplace | |
| altavoice.com | 2004 | San Mateo, United States | – | – | Patient Insight Network (PIN) helping drug developers find better treatments for diseases | |
| doctorpenguin.com | 2019 | United States | – | – | Provides an online platform with comprehensive health information for COVID-19. | |
| quosa.com | 2001 | Waltham, United States | – | – | Scientific Literature Management Software by Elsevier |
Detailed competitors of Dementias Platform
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dementias Platform
Complete news archive for Dementias Platform
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Dementias Platform
10 companies that operate in the same segment as Dementias Platform (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 617.6 M | – | – | |
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dementias Platform
Dementias Platform was founded in 2014.
Dementias Platform is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Feyi Raimi-Abraham is the current CEO of Dementias Platform. They have also founded this company.
Dementias Platform UK (DPUK) is a collaborative initiative in the UK that unites scientists and pharmaceutical leaders to advance dementia detection, treatment, and prevention. It provides a secure data portal for accessing health records, a framework for matching volunteers to clinical trials, and an incubator for developing new therapies. Through partnerships with universities and organizations, DPUK conducts research studies and offers training, aiming to improve early diagnosis and support global collaborations.
Dementias Platform offers Data Portal, Trials Delivery Framework, and Experimental Medicine Incubator.